月見草油 Evening Primrose Oil × 更年期熱潮紅
結論：證據支持
針對熱潮紅此一特定終點，現有證據雖比黑升麻分散，但整體仍屬薄弱：唯一一篇期刊級 SR/MA（2024 PMID 39829189）自評為「證據不足以下定論」；4 篇小型 RCT（n=56–80）中，僅嚴重度或夜間盜汗子項目呈現顯著差異，最關鍵的「次數」終點多為虛無；唯一 ≥6 個月雙盲 RCT（Chenoy 1994）為陰性，安慰劑反而優於 EPO；2018 頭對頭試驗中 EPO 顯著劣於黑升麻。
C 🟠 C 薄弱證據 已發布 ⚠️ medium — moderate promotional content
針對熱潮紅此一特定終點，現有證據雖比黑升麻分散，但整體仍屬薄弱：唯一一篇期刊級 SR/MA（2024 PMID 39829189）自評為「證據不足以下定論」；4 篇小型 RCT（n=56–80）中，僅嚴重度或夜間盜汗子項目呈現顯著差異，最關鍵的「次數」終點多為虛無；唯一 ≥6 個月雙盲 RCT（Chenoy 1994）為陰性，安慰劑反而優於 EPO；2018 頭對頭試驗中 EPO 顯著劣於黑升麻。
學會與三大醫療機構（NAMS 2023、Harvard、Cleveland、Mayo、NCCIH）一致 against / cautious / insufficient，無一推薦。
本層判 C 而非 D，因尚未有 Cochrane 級高品質 MA 直接判定無效，且在「嚴重度／夜間盜汗」次要終點上仍保留弱訊號；但已足夠排除「有效」之判讀。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.56
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 已發布
信心度
79%
證據方向大致一致
證據層級
E3
單篇高品質統合分析
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.561
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — | B→C 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Evening Primrose Oil for Menopause Hot Flashes: Systematic Review and Meta-Analysis
結論：EPO reduced hot flash severity vs placebo when administered <6 months, but showed no significant difference in frequency or duration; vs black cohosh EPO was equivalent at 4 weeks but inferior on severity at 8 weeks; authors concluded current evidence is insufficient for firm conclusions.
前往 PubMed
Effect of oral gamolenic acid from evening primrose oil on menopausal flushing (Chenoy)
結論：Placebo arm improved more than EPO: placebo -1.9 daytime flushes (p<0.001) vs EPO -0.5; only significant EPO finding was reduced maximum nighttime flushes (-1.4, p<0.05); high attrition (35/56 completed).
前往 PubMed
The effect of oral evening primrose oil on menopausal hot flashes: a randomized clinical trial (Farzaneh)
結論：EPO improved hot flash severity vs placebo (39% vs 32% frequency; 42% vs 32% severity, p<0.05 for severity only); HFRDIS social/relational/sexuality subscales improved significantly vs placebo (p<0.05); frequency and duration not significantly different.
前往 PubMed
A comparative study on the effect of black cohosh and evening primrose oil on menopausal hot flashes (Mehrpooya)
結論：Both arms reduced hot flash severity (p<0.001 within-group); black cohosh significantly reduced hot flash number at week 8 (p<0.001) whereas EPO did not (p=0.32); black cohosh superior to EPO on frequency and MENQOL at week 8 (p<0.05).
前往 PubMed
The Effect of Evening Primrose Oil Capsule on Hot Flashes and Night Sweats in Postmenopausal Women: A Single-Blind Randomized Controlled Trial
結論：Hot flash frequency, duration, and severity did not differ significantly between EPO and placebo arms (p>0.05); however night sweat frequency and severity were significantly lower in the EPO arm vs placebo (p<0.05).
前往 PubMed
L4a US FDA
謹慎
In 1985, FDA issued a series of Import Alerts announcing that Evening Primrose Oil could not be sold lawfully in the United States without FDA approval, that the substance did not have FDA approval, and that all import shipment of evening primrose oil offered for entry into the U.S. were to be detained by Customs. 來源↗
L4b EU EFSA
反對
L4c UK NHS
反對
[NHS.uk, menopause herbal remedies page] Evening primrose oil is listed among herbal remedies "sometimes taken for menopause symptoms"; the page warns that such herbal remedies "are not tested and regulated in the same way as medicines such as hormone replacement therapy (HRT), so it's not known how safe and effective they are", may "cause unpleasant side effects", and that "the quality, purity… 來源↗
L4d TW TFDA / 衛福部
中性
在台灣食品法規下，月見草油不得標示療效，也不得聲稱療效。除健康食品外，一般食品均不得宣稱保健功效。 來源↗
L4e WHO
未表態
— 本適應症無對應資料
L5a NIH Office of Dietary Supplements
謹慎
There's not enough evidence to support the use of evening primrose oil for any health condition. ... Evening primrose oil, taken orally, has not been shown to be helpful for relieving symptoms of atopic dermatitis. ... Evening primrose oil is probably not more effective than a placebo (an inactive substance) for breast pain. ... There's insufficient evidence to show whether evening primrose oil… 來源↗
L5b Mayo Clinic
中性
— 本適應症無對應資料
L5c Cleveland Clinic
謹慎
L5d Harvard Health
反對
L5e Specialty Society (condition-mapped)
反對
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 中度
低中高
📍立場總覽
台灣社群（PTT WomenTalk/BeautyBody、Dcard、Mobile01）對月見草油的討論幾乎集中在經痛、調經與經前症候群（PMS），鮮少有人專門針對「更年期熱潮紅」分享月見草油的成功實測。當討論到更年期/潮熱時，鄉民多半推薦大豆異黃酮，或直接建議掛婦產科、必要時做荷爾蒙補充療法，月見草油在熱潮紅議題上反而不是主流選擇。因此就「更年期熱潮紅」這個特定 condition 而言，社群訊號稀薄且分歧，無明確一致經驗可言。
💬社群實感
無共識（針對更年期熱潮紅）—社群討論主要集中於經痛/PMS，少數提及媽媽更年期服用「有感」，但同時有人反映吃了沒明顯改善潮熱，整體分歧且樣本少
破解迷思 社群最常見的 4 個誤解
✓
事實以為月見草油能直接『治療』更年期熱潮紅，把它當成荷爾蒙療法的替代品（實際證據薄弱、效果不明）
✓
事實誤認月見草油可在經期中服用以止痛（社群提醒其活血特性應在經期前服用，經期中反而可能增加出血量）
✓
事實把月見草油與大豆異黃酮混為一談、認為功效相同（兩者成分與作用機轉不同，更年期潮熱研究多指向大豆異黃酮）
✓
事實認為『天然保健品沒副作用、可長期天天吃』（社群與藥師提醒不宜連續超過約6個月、特定族群禁用）
🩹 社群通報的副作用
- 經期間服用導致經血量增加
- 腸胃不適 / 拉肚子
- 子宮肌瘤者擔心刺激增生（社群常見警告）
- 抗凝血、與薄血藥併用出血風險（社群轉述藥師提醒）
🏷️ 社群熱議品牌
依論壇被提及頻率，非銷售或品質排序。
- 長庚生技
- 三多 (SENTOSA)
- 活沛多 (屈臣氏通路)
- NOW 健而婷
- Costco / 美式賣場自有與進口品牌
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 停經期荷爾蒙治療（MHT）
- 非荷爾蒙藥物（fezolinetant、低劑量 SSRI／SNRI）
- 認知行為治療（CBT）
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-hot-flashes-INT-evening-primrose-oil-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "月見草油能改善更年期熱潮紅",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 2,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟠 C 薄弱證據"
}
}